(Total Views: 669)
Posted On: 09/01/2020 9:13:41 PM
Post# of 148908
For the physicians in the room does it make any sense that this drug has not gotten an eua with p4 for m2m given the news2 finding?
Why would it be denied when you need sepsis prevention worldwide? When minimal treatments are available or effective.
Also why no media coverage? Rlftf is doing fairly well with coverage and have not even finished their trial.
Why would there be such a long wait for an EUA?
Is Cytodyn refusing lowball buyouts? Just do not know what to think.
Why would it be denied when you need sepsis prevention worldwide? When minimal treatments are available or effective.
Also why no media coverage? Rlftf is doing fairly well with coverage and have not even finished their trial.
Why would there be such a long wait for an EUA?
Is Cytodyn refusing lowball buyouts? Just do not know what to think.
(1)
(0)Scroll down for more posts ▼
